$CWBHF Balance Sheet | Understand Stock

$CWBHF

$0.32 +$0.01 (2.83%) Close

$CWBHF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net
Notes receivable - current
Inventories, net
Employee retention credit receivable
Prepaid expenses and other current assets
Total current assets

Property and equipment, net
License and media rights
Operating lease right-of-use assets, net
Investment in unconsolidated entity
Derivative assets
Intangible assets, net
Goodwill
Stanley Brothers USA Holdings purchase option
SBH purchase option and other derivative assets
Notes receivable - noncurrent
Other long-term assets
Derivative and other long-term assets
Total assets

LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable
Accrued and other current liabilities
Cultivation liabilities – current
Lease obligations – current
License and media rights payable - current
Total current liabilities

Convertible debenture
Converted debenture
Lease obligations
Warrant and other long-term liabilities
Other long-term liabilities
License and media rights payable
Derivative and other long-term liabilities
Total liabilities
Shareholders’ equity (deficit):
Common shares, nil par value; unlimited shares authorized; 270,549,931 and 159,420,141 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Proportionate voting shares, nil par value; nil shares authorized as of September 30, 2022 and December 31, 2021, respectively; nil shares issued and outstanding as of September 30, 2022 and December 31, 2021
Additional paid-in capital
Accumulated deficit
Total shareholders’ equity (deficit)

Total liabilities and shareholders’ equity (deficit)

Common shares, outstanding (in shares)

Comments